Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
EA
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.33% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.58% |
| 5 | Consumer Staples | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAMP
2901
DELISTED
CalAmp Corp.
CAMP
| $300K | ﹤0.01% |
+561
| New | +$248K |
|
|
AKAO
2902
DELISTED
Achaogen Inc
AKAO
| $300K | ﹤0.01% |
+18,800
| New | +$358K |
|
2903
vTv Therapeutics
VTVT
$122M
| $299K | ﹤0.01% |
1,250
-597
| -32% | -$119K |
|
|
AIFC
2904
AI Financial Corp
AIFC
$58.9M
| $299K | ﹤0.01% |
58,000
+17,020
| +42% | +$82.5K |
|
|
ACCS
2905
ACCESS Newswire
ACCS
$18.7M
| $299K | ﹤0.01% |
22,400
-1,700
| -7% | -$21.5K |
|
2906
Taylor Devices
TAYD
$170M
| $297K | ﹤0.01% |
24,200
+2,600
| +12% | +$31.5K |
|
|
REED
2907
DELISTED
Reeds, Inc. Common Stock
REED
| $297K | ﹤0.01% |
2,696
+146
| +6% | +$14.2K |
|
2908
BGSF Inc
BGSF
$59.2M
| $296K | ﹤0.01% |
+17,900
| New | +$294K |
|
|
SELF
2909
Global Self Storage
SELF
$58.9M
| $296K | ﹤0.01% |
61,300
+27,600
| +82% | +$134K |
|
2910
Citizens Community Bancorp
CZWI
$204M
| $295K | ﹤0.01% |
21,159
-4,241
| -17% | -$58.6K |
|
|
ARAV
2911
DELISTED
Aravive, Inc. Common Stock
ARAV
| $295K | ﹤0.01% |
20,067
-40,351
| -67% | -$4.07M |
|
2912
Vince Holding Corp
VNCE
$78.9M
| $292K | ﹤0.01% |
48,590
+9,430
| +24% | +$50.8K |
|
2913
Woori Financial
WF
$17.2B
| $292K | ﹤0.01% |
+6,269
| New | +$306K |
|
|
ECYT
2914
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $292K | ﹤0.01% |
206,780
+86,056
| +71% | +$120K |
|
|
KA
2915
DELISTED
Kineta, Inc. Common Stock
KA
| $291K | ﹤0.01% |
+989
| New | +$378K |
|
|
VRML
2916
DELISTED
Vermillion, Inc.
VRML
| $288K | ﹤0.01% |
159,800
-41,400
| -21% | -$60.9K |
|
2917
Fortuna Silver Mines
FSM
$3.1B
| $285K | ﹤0.01% |
65,100
-487,100
| -88% | -$2.28M |
|
|
STDY
2918
DELISTED
SteadyMed Ltd
STDY
| $285K | ﹤0.01% |
85,100
-1,600
| -2% | -$8.51K |
|
2919
Daxor
DXR
$60.7M
| $284K | ﹤0.01% |
55,500
+1,400
| +3% | +$8.13K |
|
|
AINC
2920
DELISTED
Ashford Inc.
AINC
| $284K | ﹤0.01% |
4,680
+200
| +4% | +$10.8K |
|
|
DNBF
2921
DELISTED
DNB Financial Corp
DNBF
| $284K | ﹤0.01% |
8,060
+1,060
| +15% | +$35.4K |
|
|
MARK
2922
DELISTED
Remark Holdings, Inc.
MARK
| $282K | ﹤0.01% |
7,470
+3,010
| +67% | +$90.6K |
|
|
MESO
2923
Mesoblast
MESO
$2.14B
| $278K | ﹤0.01% |
25,357
+14,000
| +123% | +$188K |
|
|
WSCI
2924
DELISTED
WSI Industries Inc
WSCI
| $277K | ﹤0.01% |
83,900
+2,200
| +3% | +$6.95K |
|
|
GOLD
2925
Gold.com Inc
GOLD
$1.27B
| $276K | ﹤0.01% |
33,400
+200
| +0.6% | +$1.64K |
|
Similar funds
Jim Simons's Q3 2017 Portfolio in Review
As of Q3 2017, Jim Simons held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Jim Simons deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Jim Simons's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Jim Simons added most to Medtronic in Q3 2017, an estimated $495M increase.
- Jim Simons's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Jim Simons fully exited Amazon in Q3 2017, selling an estimated $290M.
- Jim Simons's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Jim Simons opened 418 new positions and closed 418 in Q3 2017.
- Jim Simons's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.